IRADIMED CORPORATION (IRMD)

IRADIMED CORPORATION (IRMD) is a healthcare company (medical devices) based in the United States. The share price is $83.45, down 1.64% on the day, which values the company at $1.07B. Price as of 18 Nov 2026, 12:48 UTC, from Yahoo Finance.

Key facts

Share price
$83.45−1.64% today
Market value
$1.07B
P/E ratio
44.6×last 12 months
Forward P/E
34.2×
Dividend yield
0.94%
Funk Score
77/100
Against its own history
Well above its usual priceusual price $61.95
200-week average
$61.4036% above

Figures as of . Prices from Yahoo Finance (may be delayed); statements from company filings with the SEC and Yahoo Finance. Estimates, not advice.

IRADIMED CORPORATION in more detail

IRMD trades at 44.6× its last twelve months' earnings, 34.2× next year's expected earnings, 11.9× sales. Measured against its own history, the price is 35% above what its usual multiples would imply ($61.95) — well above its usual price. It sits 36% above its 200-week average of $61.40.

Over the last five fiscal years IRADIMED CORPORATION has compounded revenue 21.5% a year, earnings per share 73.9% a year, free cash flow 25.2% a year. Its Funk Score is 77 out of 100 (financial strength 8.1, profitability 9.7, growth 9.7, value 3.2, each out of 10).

In its favour: Altman Z in the safe zone; Five straight years of revenue growth. Worth checking: Share count keeps rising.

IRADIMED CORPORATION (IRMD): questions and answers

What is IRMD's P/E ratio?

IRADIMED CORPORATION trades at 44.6× its last twelve months' earnings and 34.2× next year's expected earnings. At its fiscal year-ends over the past 12 years the P/E ranged from 18.5× to 378.7×, with a median of 46.9×.

What is IRADIMED CORPORATION's market cap?

IRADIMED CORPORATION is valued at $1.07B at a share price of $83.45.

Is IRMD overvalued or undervalued?

Against its own history, IRMD is well above its usual price: the price is 35% above the $61.95 implied by the median multiples it has traded at (price / earnings, price / sales, price / book, price / free cash flow). That compares the stock with its past; it does not say whether the business now deserves a higher or lower multiple.

Is IRMD above its 200-week moving average?

Yes. IRMD is 35.9% above its 200-week average of $61.40. Long-term investors watch that line because strong companies rarely trade below it for long.

How fast is IRADIMED CORPORATION growing?

Over the last five fiscal years IRADIMED CORPORATION's revenue grew 21.5% a year and its earnings per share 73.9% a year; over ten years revenue grew 10.2% a year.

Does IRMD pay a dividend?

Yes. IRADIMED CORPORATION's dividend yield is 0.94%, or $0.80 a share a year, paying out 41% of earnings.

Cite this page

Funkfolio, “IRADIMED CORPORATION (IRMD) stock: price, valuation and fundamentals”, data as of 18 November 2026. https://funkfolio.com/stock/IRMD

Underlying data: Yahoo Finance; company filings with the SEC.